Search results for:
glucarpidase
glucarpidase
- Provider restrictions: Restricted to hematology/oncology providers
- Patient restrictions: Restricts to patients with clinically toxic plasma methotrexate concentrations (>1 μM/L) and impaired renal function
- Patient restrictions: Requires a review of use by the HM Oncology Exception Review Panel physician
- Pharmacy Consult: Mandatory pharmacy consult to screen glucarpidase therapy
Brand names: Voraxaze
Last updated: Aug. 24, 2022
Policies and procedures
Consults, protocols, and therapeutic interchanges
Requires a mandatory “Pharmacy consult to screen glucarpidase therapy”
Additional information
Each 1,000 unit vial costs $30,753. A 50 u/kg dose in a 70 kg patient costs $123,012.